Germany

5 Vaccines Approved for Use in Germany

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
16 trials in 12 countries
Approval Source: ema.europa.eu
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
Approval Source: ema.europa.eu
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Approval Source: ema.europa.eu

16 in Clinical Trials in Germany

Protein Subunit

Clover

SCB-2019

14 trials in 13 countries
RNA

Pfizer/BioNTech

BNT162b1

5 trials in 3 countries
RNA

Pfizer/BioNTech

BNT162b2s01

3 trials in 2 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries
Protein Subunit

Tuebingen

CoVac-1

3 trials in 1 country
VLP

Radboud University

ABNCoV2

4 trials in 2 countries
RNA

Pfizer/BioNTech

BNT162a1

2 trials in 1 country
RNA

Pfizer/BioNTech

BNT162b2 (B.1.1.7 + B.1.617.2)

RNA

Pfizer/BioNTech

BNT162b2 (B.1.1.7)

RNA

Pfizer/BioNTech

BNT162b2 (B.1.617.2)

RNA

Pfizer/BioNTech

BNT162b3

2 trials in 1 country
RNA

Pfizer/BioNTech

BNT162c2

2 trials in 1 country
Non Replicating Viral Vector

Universitätsklinikum Hamburg-Eppendorf

MVA-SARS-2-ST

3 trials in 1 country
Non Replicating Viral Vector

Universitatsklinikum Hamburg-Eppendorf

MVA-SARS-2-S

1 Vaccines with Trials in Germany are No Longer Progressing

RNA

Curevac

CVnCoV

9 trials in 12 countries